A CRISPR/dCasX‐mediated transcriptional programming system for inhibiting the progression of bladder cancer cells by repressing c‐MYC or activating TP53

Detalles Bibliográficos
Autores principales: Cao, Congcong, Yao, Lin, Li, Aolin, Zhang, Quan, Zhang, Zhenan, Wang, Xiaofei, Gan, Ying, Liu, Yuchen, Zhang, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Letter to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441141/
https://www.ncbi.nlm.nih.gov/pubmed/34586743
http://dx.doi.org/10.1002/ctm2.537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441141/
https://www.ncbi.nlm.nih.gov/pubmed/34586743
http://dx.doi.org/10.1002/ctm2.537

Ejemplares similares